Countdown to ASLMS 2018!







ESLD - Laser and EBD Medicine for Breast Cancer Patients - Abstract Session

Sunday, April 9 | 7:30 AM - 10:30 AM | Room: 30 A/B

AMA PRA Category 1 CME Credits: 3.00 MAX

ACCME Accreditation Statement

Presenter Disclosures

Educational Needs This session will explore parameters for laser treatment for different skin lesions for multiple medical indications that may still need optimization. It is a challenge for the practicing physician to choose not only the right device for the intervention but also the choice of parameters remains a challenge as research is often still unsatisfactory. By actively exchanging and discussing device choices and treatments parameters for different medical indications the participant will enhance their knowledge about laser and energy-based devices, will be more at ease with laser and energy based device settings and ultimately will have satisfying outcomes for the physician and most of all for their patients.

Participants Any practitioner using laser and energy-based devices in medical applications.

Background Requirements A solid background knowledge of laser and energy-based device application will be helpful to join the in depth discussion. However even beginning laser and energy-based device practitioners will have the opportunity to discuss their difficulties encountered in their daily practice.

Instructional Content/Expected Learning Objectives The attendees are expected to come out after the session with a better understanding about how to optimize laser parameters for specific indications to improve the outcome and avoid unwanted side effects. Attendants will also learn about new indications in which laser and energy-based devices might be a valid alternative treatment tool. Attendees will furthermore have the opportunity to learn about and share their own practical treatment pearls within the discussion of each presentation.

"Hot topics"

  • Prevention of acute and treatment of chronic radiation dermatitis: although significant improvements have been made in the last decades in radiotherapy, radiation dermatitis is still a problem facing a large percentage of the treated patients.
  • Photobiomodulation appears to be a safe and effective tool to drastically reduce the incidence of acute radiation dermatitis. Unfortunately it is not used in the daily routine yet.
  • Chronic radiation dermatitis is affecting up to 1/3 of breast cancer patients 10 years after radiotherapy. Vascular lasers have been shown to improve quality of life of the affected patient. ESLD public awareness campaign tries to make physicians and patients aware of this effective treatment modality.
  • Panel discussion regarding the ASLMS New Beginnings Radiation Mark Removal and the ESLD Chronic Radiation Dermatitis public awareness and treatment campaigns. 

Chair(s) Ashraf M. Badawi, MD, PhD; Hans Joachim Laubach, MD

Abstract Presentations

Time Abstr Activity
7:30 AM - 7:35 AM   Introduction
7:36 AM - 7:51 AM


Best of ESLD Laser and EBD Medicine for Breast Cancer Patients Award Recipient:
PREVENTION OF ACUTE RADIODERMATITIS BY PHOTOBIOMODULATION: PRELIMINARY RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED TRIAL IN BREAST CANCER PATIENTS Jolien Robijns★✈, Sandrine Censabella, Stefan Claes, Lore Busse, Annelies Maes, Paul Bulens, Niels Hellings, Ivo Lambrichts, An Timmermans, Veerle Somers, Jeroen Mebis | Hasselt University, Hasselt, Limburg, Belgium; Jessa Hospital, Hasselt, Limburg, Belgium
7:52 AM - 7:57 AM   Q&A
7:58 AM - 8:08 AM   114 TREATMENT OF CHRONIC RADIODERMATITIS WITH VASCULAR LASERS Jean-Michel Mazer★, Noel Schartz, Gwendoline Sebille, Marie Jourdan | Centre Laser International de la Peau Paris, Paris, France
8:09 AM - 8:14 AM   Q&A
8:15 AM - 8:25 AM   115 Best Overall Basic Science and Translational Research Award Recipient:
EFFECT OF LASER THERAPY ON QUALITY OF LIFE IN PATIENTS WITH RADIATION-INDUCED BREAST TELANGIECTASIAS Nina Blank★✈, Anthony Rossi, Kishwer Nehal, Stephen Dusza, Erica Lee | Memorial Sloan Kettering Cancer Center, New York, NY
8:26 AM - 8:31 AM   Q&A
8:32 AM - 8:42 AM   116 EPIDEMIOLOGICAL DATA CONCERNING "LASER TREATMENTS FOR BREAST CANCER SURVIVORS" PUBLIC AWARENESS CAMPAIGN Hans-Joachim Laubach★, Yvon Perrillat, Jean Michel Mazer, Hugues Cartier | University Hospital of Geneva, Geneva, Switzerland; Private Practice, Grenoble, Isere, France; CLIPP, Geneva, Ile de France, France; Cabinet Privé, Arras, Pas de Calais, France
8:43 AM - 8:48 AM   Q&A
8:49 AM - 8:59 AM   117 TREATMENT OF RADIATION TATTOOS WITH A PLATFORM-BASED QS Nd:YAG 1064nm LASER Girish Munavalli★ | Dermatology, Laser, and Vein Specialists of the Carolinas, PLLC, Charlotte, NC; Wake Forest School of Medicine, Winston Salem, NC
9:00 AM - 9:04 AM   Q&A
9:05 AM - 9:15 AM  LB22 CRYOLIPOLYSIS FOR NON-SURGICAL REDUCTION OF LATERAL CHEST WALL FAT POST-MASTECTOMY Peter Capizzi★, Jennifer Harrington Capizzi MD, Charlotte, NC; Harrington Plastic Surgery, Plymouth, MN
9:16 AM - 9:21 AM   Q&A
9:33 AM - 9:38 AM   Q&A and Conclusion

Panel Discussion: ASLMS New Beginnings Radiation Mark Removal and ESLD Chronic Radiation Dermatitis Treatment Program

Speaker(s) Brian S. Biesman, MD; Hans Joachim Laubach, MD; Jean-Michael Mazer, MD; Anthony M. Rossi, MD; Emil Tanghetti, MD;

Time   speaker  TopiC
9:39 AM - 9:47 AM 

Ashraf Badawi, Hans Joachim Laubach

Introduction to Panel Discussion
9:48 AM - 9:53 AM  Emil A. Tanghetti ASLMS - New Beginnings Radiation Mark Removal
9:54 AM - 9:59 AM  Brian S. Biesman 
10:00 AM - 10:05 AM  Jean-Michel Mazer  ESLD - Chronic Radiation Dermatitis Treatment
10:06 AM - 10:11 AM  Hans Joachim Laubach 
10:12 AM - 10:17 AM  Anthony M. Rossi  
10:18 AM - 10:30 AM    Q&A, Conclusion and Recommendations 
Schedule and rooms subject to change without notice
★ Presenter | ✈ ASLMS Travel Grant Recipient

The American Society for Laser Medicine and Surgery is the world’s largest scientific organization dedicated to promoting research, education and high standards of clinical care in the field of medical laser applications. It provides a forum for the exchange of scientific information and participation in communicating the latest developments in laser medicine and surgery to clinicians, research investigators, government and regulatory agencies, and the public.

Connect with ASLMS!